US Airways Group Inc. (NYSE:LCC): The stock is moving on the news of its impending merger with American Airlines. The announcement is expected to be made within this week.
The deal is expected to be worth $11 billion and is likely to be an all stock merger. The boards of these companies are expected to meet this week to take decision on the merger. The deal, if successful, will lead to the creation of $11 billion entity, posing considerable competition to airlines companies like Delta Air Lines and United Continental Holdings. The company stock is currently trading at $14.71, down 0.25 percent from its previous close of $14.75. The stock had opened at $14.89 and has traded in the range of $14.69 and $15.01 in the current trading session. It has traded 612K shares as of now. US Airways Group commands market capitalization of $2.43 billion and its Price Earnings ratio is 4.56. The company stock’s beta stands at 0.37.
Novo Nordisk (NYSE:NVO): The stock tumbled down after the company received disappointing news about its Tresiba and Ryzodeg drug products. FDA refused approval for these drugs. These products were meant for treating insulin. Novo Nordisk also announced that the FDA has asked for additional trial data. However, the company is not in position to provide such data during the current year. The drugs were filed for approval in 2011. The stock is trading 13.22 percent lower, at $166.87. The company has traded 565K shares in the current trading sessions so far and its stock has traded in the range of $129.41 and $194.44 in the past 52 weeks. The company stock’s beta is 1.12, while its P/E ratio stands at 24.70. It had reported its latest Earnings per Share at $6.74. However, the company clarified that the decline is not likely to have any impact on its financial performance in 2013.
Loews Corporation (NYSE:L): The stock is trading at $43.36, 1.12 percent lower than its previous close of $43.85 on the news of its quarterly results. Loews Corporation reported a loss of $32 million in its fourth quarter, compared to net income of $271 million it had reported for the previous year quarter. Its full year net income stood at $568 million, down from $1.1 billion it had earned in FY 2011. It has traded in the range of $43.24 and $43.80 in the current trading session. It has traded 82K shares so far, in comparison to its daily average trading volume of 1.01 million shares. The stock has traded in the range of $37.58 and $44.13 in the past 52 weeks. The company stock trades at Price Earnings ratio of 19.75 and its beta is at 1.05. Loews Corporation also reported buying 5.6 million shares of its stock during the year. The overall outlay stood at$222 million.
Sensient Technologies Corporation (NYSE:SXT): the company reported lower profits for its fourth quarter. Sensient Technologies earned $27.2 million for the fourth quarter, down 5 percent from the previous year quarter. However, its revenue inched up 5 percent to $356.2 million. Consequent to its results declaration, the company stock traded in the range of $37.25 and $37.36 in the current trading session and at this point is at $37.30, down 0.08 percent. The stock’s highest price point of 52 weeks stands at $39.25 while its lowest price point is at $33.13. Sensient Technologies stock is trading at Price Earnings ratio of 14.96 and its beta is 1.07. The company’s dividend yield stands at 2.40 percent. The company also reported 3 percent increase in its full year net income to $123.9 million. Its full year revenue increased to $1.5 billion, up 2 percent.
Molina Healthcare Inc. (NYSE:MOH): It is currently trading at $31.05, down 2.62 percent. It is trading in the range of $30.83 and $31.49 in the current trading session. Molina Healthcare reported its revenue at $1.58 billion for the fourth quarter of the year, up from $1.31 billion it had reported for the corresponding quarter of the last year. The stock is lower than its 20 days moving average price of $31.29 and 50 days moving average price of $31.56. In the past 52 weeks, the stock’s price range has been $17.63 and $36.83. The stock’s beta is 1.20 and its Price Earnings ratio is 157.69. Molina commands market capitalization of $1.45 billion.